Zogenix, Inc. announced that Ashish Sagrolikar has joined the company as Executive Vice President and Chief Commercial Officer. Mr. Sagrolikar has over 25 years of global pharmaceutical sales, marketing and operations experience. Prior to joining the company, he spent the last 16 years leading commercial strategies for rare disease and specialty pharmaceutical products, most recently at GlaxoSmithKline (GSK) and Baxter International. Mr. Sagrolikar has held increasingly senior marketing and commercial leadership roles in pharmaceutical companies across four continents, including the United States, over a 25-year career. Most recently, as Vice President of Commercial Transformation and VP of Immunology Marketing and Rare Disease at GSK, he led the efforts to develop the rare disease business unit, building a high performing commercial team for BENLYSTA®, a treatment for lupus, and building a nimble operating model to accelerate growth for specialty therapies.